Surface ECG Mapping

Electrocardiogram Clinical Trial

Official title:

Surface ECG Mapping in Healthy Adult Volunteers

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT04221958
• Other study ID #: 54619
• Status: Enrolling by invitation
• Start date: January 2024
• Est. completion date: December 2024

Study information

• Verified date: April 2023
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to confirm a scientific concept that superficially placed electrocardiogram (ECG) leads may be compared to one another to help determine positioning. If proven to be effective, this could offer a more non-invasive means of positioning using superficial ECG tracings.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 5
• Est. completion date: December 2024
• Est. primary completion date: December 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult volunteers from institution's staff

• Age >18 years

Exclusion Criteria:

• Existing heart conditions

Related Conditions & MeSH terms

• Electrocardiogram

Intervention

Device:
• Electrocardiogram
An electrocardiogram measures the electrical activity of the heartbeat. This "intervention" will be used on healthy adult volunteers whom are part of the staff at the institution.

Locations

Country	Name	City	State
United States	Stanford Health Care	Stanford	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ECG Tracing	ECG tracing for each electrode will be recorded in voltage per unit of time.	Approximately 30 minutes